Home » Topics » Conferences

Conferences
RSS

Antiasthma drug candidate enters phase I testing at Pharmacia & Upjohn

Aug. 25, 1998

International team identifies selective P2X antagonists

Aug. 21, 1998

Russian researchers describe immunomodulatory activity of thiethazole

Aug. 20, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

HMR-4902 protects against acute renal failure in rats

Aug. 20, 1998

Clinical evaluation of gossypol in malignant gliomas

Aug. 20, 1998

Antiarthritic activity of cromoglicate lisetil in a model of immunologically-mediated disease

Aug. 20, 1998

NK1 antagonist GR-205171 prevents nephrotoxicity in cisplatin-treated rats

Aug. 20, 1998

GVS-111, a novel cognition-enhancing agent with a multifaceted mechanism of action

Aug. 20, 1998

Preclinical studies suggest that Tanabe's ETA antagonist holds promise for treating heart failure

Aug. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...